Corcept Therapeutics reported $23.52M in Trade Creditors for its fiscal quarter ending in June of 2025.


Trade Creditors Change Date
Acadia Pharmaceuticals USD 20.1M 2M Jun/2025
Alaunos Therapeutics USD 516K 58K Dec/2024
ANI Pharmaceuticals USD 54.57M 1.51M Jun/2025
Ardelyx USD 21.68M 5.68M Jun/2025
Aurora Cannabis CAD 81.29M 51.77M Jun/2025
BioMarin Pharmaceutical 684.25M 390.5M Jun/2025
Bristol-Myers Squibb USD 5.43B 1.42B Jun/2025
Canopy Growth CAD 24.08M 4.84M Jun/2025
Corcept Therapeutics USD 23.52M 4.42M Jun/2025
Eli Lilly USD 4.08B 633.7M Jun/2025
J&J USD 9.54B 766M Mar/2025
Merck USD 4.04B 261M Jun/2025
Novartis USD 4.51B 245M Jun/2025
Novartis USD 4.51B 66M Jun/2025
Pacira USD 30.12M 6.95M Jun/2025
Pfizer USD 5.17B 74M Jun/2025
Supernus Pharmaceuticals USD 8.22M 1.14M Jun/2025
TG Therapeutics 134.02M 92.06M Jun/2025